Selected Publications

Heta Patel, Harper Hubbeling, Kyle L. Yu, Maribel Carpenter, Michael J. LaRiviere, John P. Plastaras, Adam D. Cohen, Shivani Kapur, Dan T Vogl, Adam J Waxman, Edward A Stadtmauer, Alfred L Garfall, Sandra Patricia Susanibar-AdaniyaCorresponding Author : Outcomes of Radiation Integrated with T-cell-engaging Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma. blood adv Dec 2025.

Kyle L. Yu, Matthew Ho, Luca Paruzzo, Federico Stella, Heta Patel, Zainul S. Hasanali, Shivani Kapur, Adam J. Waxman, Dan T. Vogl, Edward A. Stadtmauer, Joseph A. Fraietta, Marco Ruella, Adam D. Cohen, Alfred L. Garfall & Sandra Susanibar-Adaniya : Outcomes of relapse after teclistamab therapy in multiple myeloma. Blood Cancer Journal 15(1), Nov 2025.

Beatrice M. Razzo; Shonali Midha; Andrew J. Portuguese ; Ariel F. Grajales-Cruz; Andre De Menezes Silva Corraes ; Patrick Costello; Yuxin Liu; Adam S. Sperling; Omar Nadeem ; Danai Dima; Rahul Banerjee; Andrew J.Rowan; Aimaz Afrough; Larry D. Anderson; Alex Lieberman-Cribbin; Gurbakhash Kaur; Anmol Goyal; Shebli Atrash; Christopher J. Ferreri; Peter M. Voorhees; Oren Pasvolsky; Hans C. Lee; Krina K. Patel; Kelley L. Julian; Peter A. Forsberg; Megan M. Herr; Saurabh Chhabra; Ricardo D. Parrondo; Yi Lin; Anna Chen; Sandra P. Susanibar-Adaniya; Jack Khouri; Shahzad Raza; Faiz Anwer; Mariola Vazquez-Martinez; Omar Castaneda Puglianini ; Douglas W. Sborov; James A. Davis ; Adriana Rossi; Leyla Shune; Jenny Bhurtel; Wei-Ting Hwang; Doris K. Hansen; Surbhi Sidana; Alfred L. Garfall;Shambavi Richard: Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium. Blood Cancer Discovery July 2025.

Luca Paruzzo, Khashayar Eshaghi, Guido Ghilardi, Abigail Doucette, Matthew Ho, Alberto Carturan, Dan T. Vogl, Adam J. Waxman, Shivani Kapur, Eugenio Fardella, Martina Pucillo, Antonio Imparato, Federico Stella, Puneeth Guruprasad, Vitor B. De Souza, Luke Maillie, Sofia Kaparis, Riemke Bouvier Bs, Adam D. Cohen, Jalpa A. Doshi, David L. Porter, Alfred L. Garfall , Edward A. Stadtmauer, Carmen E. Guerra, Sandra P. Susanibar Adaniya, Marco Ruella: Access and Outcomes of Racial and Ethnic Minority Populations Receiving Commercial Anti-BCMA CART for Myeloma Blood Immunology & Cellular Therapy July 2025.

Oren Pasvolsky, Danai Dima, Lei Feng, Wenli Dong, Tiffany Richards , James A Davis, Aimaz Afrough, Mariola Vazquez-Martinez, Aishwarya Sannareddy, Utkarsh Goel, Rahul Banerjee, Jack Khouri, Frances Cervoni, Mahmoud R Gaballa, Alex Lieberman-Cribbin, Masooma Shifa Rana, Kelley Julian, Christopher J Ferreri, Leyla Shune, Shaun DeJarnette, Evguenia Bhurtel, Sandra Susanibar Adaniya 13, Andrew Portuguese 2, Hitomi Hosoya 9, Lekha Mikkilineni 9, Gurbakhash Kaur, Adriana Rossi, Megan M Herr, Daniel Schrum, Chenyu Lin, Shahzad Raza, Yi Lin, Shonali Midha, Nadeem Omar, Shebli Atarsh, Joseph McGuirk, Douglas Sborov, Peter Voorhees, Faiz Anwer, Melissa Alsina, Ciara Freeman, Alfred L Garfall, Beatrice M Razzo, Surbhi Sidana, Andrew J Cowan, Larry D Anderson Jr, Doris K Hansen, Shambavi Richard, Krina K Patel, Hans C Lee, Ariel Grajales-Cruz : Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium. Blood Cancer Journal May 2025.

Xinhe Shan, Rowan Kuiper, Chuling Ding, Pashna N Munshi, Edward A Stadtmauer, Sandra P Susanibar-Adaniya: Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based study. Haematologica May 2025.

Dima D, Afrough A, Goel U, Grajales-Cruz A, Khouri J, Julian K, Pasvolsky O, Banerjee R, Razzo B, Ferreri CJ, Vazquez Martinez MA, Davis JA, Sannareddy A, Castaneda Puglianini O, Raza S, Portuguese AJ, Gaballa MR, Rana M, Lieberman-Cribbin A, DeJarnette S, Gonzalez R, Chen A, Herr MM, Mikkilineni L, Hosoya H, Ouchveridze E, Kaur G, Rossi AC, Shune L, Anwer F, Lin Y, Richard S, Sborov DW, Baz RC, Garfall A, Lee HC, Anderson LD Jr, Cowan AJ, Patel KK, Voorhees PM, Sidana S, Hansen DK, Atrash S, Susanibar-Adaniya SP.: Teclistamab for Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma and Renal Impairment. Blood Advances April 2025.

Matthew Ho, Luca Paruzzo, Janna Minehart, Teja Voruganti, Pooja Devi Dan T. Vogl, Adam D. Cohen, Alfred L. Garfall, Adam J. Waxman, Shivani Kapur, Edward A. Stadtmauer, Sandra Susanibar Adaniya, Sarah Longworth: Nontuberculous mycobacterial infections following teclistamab in multiple myeloma. Haematologica February 2025.

Guido Ghilardi, Zainul S. Hasanali, Sandra P. Susanibar-Adaniya, Lena E. Winestone, Marco Ruella and Alfred L. Garfall: Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review. Journal for ImmunoTherapy of Cancer 13, January 2025.

Margaret Stalker, Alfred Garfall, Adam Cohen, Dan T. Vogl, Mia Djulbegovic, Sandra Susanibar-Adaniya, Edward Stadtmauer, Oxana Megherea, Adam J. Waxman: Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis. European Journal of Hematology November 2024.